These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30745564)

  • 1. PET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress model.
    Reisinger SN; Wanek T; Langer O; Pollak DD
    Transl Psychiatry; 2019 Feb; 9(1):80. PubMed ID: 30745564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB.
    Burokas A; Martín-García E; Gutiérrez-Cuesta J; Rojas S; Herance JR; Gispert JD; Serra MÁ; Maldonado R
    J Neurochem; 2014 Jul; 130(1):126-35. PubMed ID: 24646401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.
    Wilson AA; Ginovart N; Hussey D; Meyer J; Houle S
    Nucl Med Biol; 2002 Jul; 29(5):509-15. PubMed ID: 12088720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
    Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
    J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
    Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
    Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.
    Szabo Z; McCann UD; Wilson AA; Scheffel U; Owonikoko T; Mathews WB; Ravert HT; Hilton J; Dannals RF; Ricaurte GA
    J Nucl Med; 2002 May; 43(5):678-92. PubMed ID: 11994534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.
    Frick A; Åhs F; Palmquist ÅM; Pissiota A; Wallenquist U; Fernandez M; Jonasson M; Appel L; Frans Ö; Lubberink M; Furmark T; von Knorring L; Fredrikson M
    Mol Psychiatry; 2016 Oct; 21(10):1400-7. PubMed ID: 26619809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography.
    Taylor O; Van Laeken N; De Vos F; Polis I; Bosmans T; Goethals I; Achten R; Dobbeleir A; Vandermeulen E; Baeken C; Saunders J; Peremans K
    BMC Vet Res; 2015 Dec; 11():308. PubMed ID: 26704517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
    Ichise M; Vines DC; Gura T; Anderson GM; Suomi SJ; Higley JD; Innis RB
    J Neurosci; 2006 Apr; 26(17):4638-43. PubMed ID: 16641244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
    Hesse S; Brust P; Mäding P; Becker GA; Patt M; Seese A; Sorger D; Zessin J; Meyer PM; Lobsien D; Laudi S; Habermann B; Füchtner F; Luthardt J; Bresch A; Steinbach J; Sabri O
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1001-11. PubMed ID: 22349718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET.
    Kang HH; Wang CH; Chen HC; Li IH; Cheng CY; Liu RS; Huang WS; Shiue CY; Ma KH
    Neuroimage; 2013 Jul; 75():262-269. PubMed ID: 22766166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
    Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
    Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B
    Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.